R Paul Wadwa

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. ncbi Continuous glucose monitoring in youth with type 1 diabetes
    R Paul Wadwa
    Barbara Davis Center for Childhood Diabetes, Aurora, Colorado 80045, USA
    Diabetes Technol Ther 11:S83-91. 2009
  2. ncbi Measures of arterial stiffness in youth with type 1 and type 2 diabetes: the SEARCH for diabetes in youth study
    R Paul Wadwa
    Barbara Davis Center for Childhood Diabetes, University of Colorado School ofMedicine, Aurora, Colorado, USA
    Diabetes Care 33:881-6. 2010
  3. ncbi Age and sex influence cystatin C in adolescents with and without type 1 diabetes
    David M Maahs
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado, USA
    Diabetes Care 34:2360-2. 2011
  4. ncbi ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification
    David M Maahs
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, CO, USA
    J Diabetes Complications 21:273-9. 2007
  5. ncbi Determinants of serum adiponectin in persons with and without type 1 diabetes
    David M Maahs
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, CO 80045, USA
    Am J Epidemiol 166:731-40. 2007
  6. ncbi Dyslipidemia in youth with diabetes: to treat or not to treat?
    David M Maahs
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, CO 80045, USA
    J Pediatr 153:458-65. 2008
  7. ncbi Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis
    Adam Kretowski
    Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, Mail Stop A140, P O Box 6511, Aurora, CO 80045 6511, USA
    Diabetes 56:863-71. 2007
  8. ncbi Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control study
    John Guy
    Department of Epidemiology, Colorado School of Public Health, University of Colorado, Denver, Colorado, USA
    Diabetes Care 32:416-20. 2009
  9. ncbi Longitudinal lipid screening and use of lipid-lowering medications in pediatric type 1 diabetes
    David M Maahs
    Barbara Davis Center for Childhood Diabetes and the Department of Medicine, University of Colorado Health Sciences Center, Aurora, Colorado 80045, USA
    J Pediatr 150:146-50, 150.e1-2. 2007
  10. ncbi Hypoglycemia, diabetes, and cardiovascular disease
    Janet K Snell-Bergeon
    Barbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Center, Aurora, Colorado 80045, USA
    Diabetes Technol Ther 14:S51-8. 2012

Detail Information

Publications18

  1. ncbi Continuous glucose monitoring in youth with type 1 diabetes
    R Paul Wadwa
    Barbara Davis Center for Childhood Diabetes, Aurora, Colorado 80045, USA
    Diabetes Technol Ther 11:S83-91. 2009
    ..In the future, CGM use in youth may couple with insulin pump technology to create a "closed-loop" system in which the CGM device will direct insulin administration without user input...
  2. ncbi Measures of arterial stiffness in youth with type 1 and type 2 diabetes: the SEARCH for diabetes in youth study
    R Paul Wadwa
    Barbara Davis Center for Childhood Diabetes, University of Colorado School ofMedicine, Aurora, Colorado, USA
    Diabetes Care 33:881-6. 2010
    ..We identified factors associated with arterial stiffness in youth with diabetes and assessed the effects of these factors on the relationship between arterial stiffness and diabetes type (type 1 vs. type 2)...
  3. ncbi Age and sex influence cystatin C in adolescents with and without type 1 diabetes
    David M Maahs
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado, USA
    Diabetes Care 34:2360-2. 2011
    ..To compare serum cystatin C levels, a novel biomarker of renal function, in adolescents with and without type 1 diabetes and to determine what factors affect cystatin C levels...
  4. ncbi ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification
    David M Maahs
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, CO, USA
    J Diabetes Complications 21:273-9. 2007
    ....
  5. ncbi Determinants of serum adiponectin in persons with and without type 1 diabetes
    David M Maahs
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, CO 80045, USA
    Am J Epidemiol 166:731-40. 2007
    ..Although some of the difference can be explained, further study is needed to better understand the relation between elevated adiponectin levels and patient outcomes, including coronary heart disease...
  6. ncbi Dyslipidemia in youth with diabetes: to treat or not to treat?
    David M Maahs
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, CO 80045, USA
    J Pediatr 153:458-65. 2008
  7. ncbi Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis
    Adam Kretowski
    Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, Mail Stop A140, P O Box 6511, Aurora, CO 80045 6511, USA
    Diabetes 56:863-71. 2007
    ....
  8. ncbi Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control study
    John Guy
    Department of Epidemiology, Colorado School of Public Health, University of Colorado, Denver, Colorado, USA
    Diabetes Care 32:416-20. 2009
    ....
  9. ncbi Longitudinal lipid screening and use of lipid-lowering medications in pediatric type 1 diabetes
    David M Maahs
    Barbara Davis Center for Childhood Diabetes and the Department of Medicine, University of Colorado Health Sciences Center, Aurora, Colorado 80045, USA
    J Pediatr 150:146-50, 150.e1-2. 2007
    ..Because cardiovascular disease (CVD) is the leading cause of death in patients with type 1 diabetes (T1D) and dyslipidemia is an important CVD risk factor, we investigated dyslipidemia and its treatment in children with T1D...
  10. ncbi Hypoglycemia, diabetes, and cardiovascular disease
    Janet K Snell-Bergeon
    Barbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Center, Aurora, Colorado 80045, USA
    Diabetes Technol Ther 14:S51-8. 2012
    ....
  11. ncbi Glucose control predicts 2-year change in lipid profile in youth with type 1 diabetes
    David M Maahs
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, CO, USA
    J Pediatr 162:101-7.e1. 2013
    ..To test the hypothesis that a change in glycated hemoglobin (A1c) over a follow-up interval of approximately 2 years would be associated with concomitant changes in fasting lipids in individuals with type 1 diabetes (T1D)...
  12. ncbi Cardiovascular disease risk in youth with diabetes mellitus
    R Paul Wadwa
    Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, PO Box 6511, MS A140, 1775 N Ursula St, Aurora, CO 80045 6511, USA
    Rev Endocr Metab Disord 7:197-204. 2006
    ..Current roles of inflammatory markers and measures of subclinical vascular changes such as arterial stiffness are also discussed...
  13. ncbi Lessons learned from a lipid lowering trial in adolescents with type 1 diabetes
    Franziska K Bishop
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, 1775 Aurora Ct, Mail Stop F527, Aurora, CO, 80045, USA
    Int J Pediatr Endocrinol 2012:24. 2012
    ..Based on our experience, future studies will require multiple centers to enroll a sufficient number of participants for adequate data to direct dyslipidemia medication treatment guidelines for adolescents with type 1 diabetes...
  14. ncbi Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes
    R Paul Wadwa
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, 80045, USA
    Int J Biochem Cell Biol 38:996-1003. 2006
    ....
  15. ncbi Oral Health Knowledge and Behaviors among Adolescents with Type 1 Diabetes
    Valerie A Orlando
    Department of Community and Behavioral Health, Colorado School of Public Health, University of Colorado Denver, Aurora, CO 80045, USA
    Int J Dent 2010:942124. 2010
    ..Significant opportunity exists for improving periodontal disease knowledge and adoption of preventive oral hygiene behaviors in adolescents with diabetes...
  16. ncbi Noninvasive measures of cardiovascular changes in diabetes mellitus
    R Paul Wadwa
    Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado 80045 6511, USA
    Curr Opin Endocrinol Diabetes Obes 14:263-8. 2007
    ..Such markers have gained popularity for research and clinical use. This paper reviews recent studies using noninvasive technology for detection and monitoring of cardiovascular disease as it pertains to diabetes patients...
  17. ncbi Total cholesterol and high-density lipoprotein levels in pediatric subjects with type 1 diabetes mellitus
    David M Maahs
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    J Pediatr 147:544-6. 2005
    ..7%, 11.2%, and 16.3%, respectively, reported in the National Health and Nutrition Examination Survey 2001-02. Hemoglobin A1c value was significantly related to TC and non-HDL cholesterol levels...
  18. ncbi Awareness and treatment of dyslipidemia in young adults with type 1 diabetes
    R Paul Wadwa
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East 9th Ave, Box B140, Denver, CO 80262, USA
    Diabetes Care 28:1051-6. 2005
    ..In this report, we describe the prevalence of dyslipidemia and adequacy of pharmacological treatment in patients with type 1 diabetes and comparable nondiabetic subjects...